Annual D&A
$115.20 K
+$1500.00+1.32%
December 31, 2023
Summary
- As of February 7, 2025, EPRX annual depreciation & amortization is $115.20 thousand, with the most recent change of +$1500.00 (+1.32%) on December 31, 2023.
- During the last 3 years, EPRX annual D&A has risen by +$28.00 thousand (+32.11%).
- EPRX annual D&A is now -24.31% below its all-time high of $152.20 thousand, reached on December 1, 2019.
Performance
EPRX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$37.80 K
-$4200.00-10.00%
September 1, 2024
Summary
- As of February 7, 2025, EPRX quarterly depreciation & amortization is $37.80 thousand, with the most recent change of -$4200.00 (-10.00%) on September 1, 2024.
- Over the past year, EPRX quarterly D&A has dropped by -$4200.00 (-10.00%).
- EPRX quarterly D&A is now -19.40% below its all-time high of $46.90 thousand, reached on December 1, 2022.
Performance
EPRX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$158.40 K
-$900.00-0.56%
September 1, 2024
Summary
- As of February 7, 2025, EPRX TTM depreciation & amortization is $158.40 thousand, with the most recent change of -$900.00 (-0.56%) on September 1, 2024.
- Over the past year, EPRX TTM D&A has dropped by -$900.00 (-0.56%).
- EPRX TTM D&A is now -1.74% below its all-time high of $161.20 thousand, reached on September 30, 2023.
Performance
EPRX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
EPRX Depreciation And Amortization Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +1.3% | -10.0% | -0.6% |
3 y3 years | +32.1% | +16.3% | +81.0% |
5 y5 years | +18.6% | +3.3% | +332.8% |
EPRX Depreciation And Amortization Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +29.4% | -19.4% | +20.0% | -1.7% | +81.0% |
5 y | 5-year | -24.3% | +32.1% | -19.4% | +136.3% | -1.7% | +332.8% |
alltime | all time | -24.3% | +74.8% | -19.4% | +136.3% | -1.7% | +332.8% |
Eupraxia Pharmaceuticals Depreciation And Amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $37.80 K(-10.0%) | $158.40 K(-0.6%) |
Jun 2024 | - | $42.00 K(+12.3%) | $159.30 K(+2.5%) |
Mar 2024 | - | $37.40 K(-9.2%) | $155.40 K(-0.1%) |
Dec 2023 | $115.20 K(+1.3%) | $41.20 K(+6.5%) | $155.50 K(-3.5%) |
Sep 2023 | - | $38.70 K(+1.6%) | $161.20 K(+4.0%) |
Jun 2023 | - | $38.10 K(+1.6%) | $155.00 K(+0.7%) |
Mar 2023 | - | $37.50 K(-20.0%) | $153.90 K(+4.1%) |
Dec 2022 | $113.70 K | - | - |
Dec 2022 | - | $46.90 K(+44.3%) | $147.90 K(+10.8%) |
Sep 2022 | - | $32.50 K(-12.2%) | $133.50 K(+8.3%) |
Jun 2022 | - | $37.00 K(+17.5%) | $123.30 K(+19.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | $31.50 K(-3.1%) | $103.00 K(+17.7%) |
Dec 2021 | $89.00 K(+2.1%) | $32.50 K(+45.7%) | $87.50 K(+15.3%) |
Sep 2021 | - | $22.30 K(+33.5%) | $75.90 K(+8.0%) |
Jun 2021 | - | $16.70 K(+4.4%) | $70.30 K(-0.8%) |
Mar 2021 | - | $16.00 K(-23.4%) | $70.90 K(-22.5%) |
Dec 2020 | $87.20 K(-42.7%) | $20.90 K(+25.1%) | $91.50 K(+29.6%) |
Sep 2020 | - | $16.70 K(-3.5%) | $70.60 K(+31.0%) |
Jun 2020 | - | $17.30 K(-52.7%) | $53.90 K(+47.3%) |
Mar 2020 | - | $36.60 K | $36.60 K |
Dec 2019 | $152.20 K(+56.7%) | - | - |
Dec 2018 | $97.10 K(+47.3%) | - | - |
Dec 2017 | $65.90 K | - | - |
FAQ
- What is Eupraxia Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Eupraxia Pharmaceuticals?
- What is Eupraxia Pharmaceuticals annual D&A year-on-year change?
- What is Eupraxia Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Eupraxia Pharmaceuticals?
- What is Eupraxia Pharmaceuticals quarterly D&A year-on-year change?
- What is Eupraxia Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Eupraxia Pharmaceuticals?
- What is Eupraxia Pharmaceuticals TTM D&A year-on-year change?
What is Eupraxia Pharmaceuticals annual depreciation & amortization?
The current annual D&A of EPRX is $115.20 K
What is the all time high annual D&A for Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals all-time high annual depreciation & amortization is $152.20 K
What is Eupraxia Pharmaceuticals annual D&A year-on-year change?
Over the past year, EPRX annual depreciation & amortization has changed by +$1500.00 (+1.32%)
What is Eupraxia Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of EPRX is $37.80 K
What is the all time high quarterly D&A for Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals all-time high quarterly depreciation & amortization is $46.90 K
What is Eupraxia Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, EPRX quarterly depreciation & amortization has changed by -$4200.00 (-10.00%)
What is Eupraxia Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of EPRX is $158.40 K
What is the all time high TTM D&A for Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals all-time high TTM depreciation & amortization is $161.20 K
What is Eupraxia Pharmaceuticals TTM D&A year-on-year change?
Over the past year, EPRX TTM depreciation & amortization has changed by -$900.00 (-0.56%)